CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AACR Annual Meeting

NEXT STORY
BriaCell Announces Presentation of Clinical and Scientific Findings at AACR Annual Meeting
PREV STORY
Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genocea to Present at Cantor Fitzgerald Healthcare Conference

CAMBRIDGE, Mass., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

In-Situ Hybridization Market Size to Reach USD 1,556.6 Million in 2028 | Increasing Technological Advancement and Availability of Diagnostic Solutions will Drive Industry Growth, says Emergen Research

author_avatar
NASDAQ Market News

athenahealth Partners with Specialty Medical Societies to Roll Out Network Medicine Health Campaigns

ORLANDO, Fla., Feb. 20, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider ...

author_avatar
NASDAQ Market News